915230-46-5 Usage
Imidazole derivative
A derivative of imidazole This means that the compound is structurally related to imidazole, a five-membered ring system with one nitrogen atom and one double bond, and has been modified to include additional functional groups.
Carboxylic acid group
Presence of -COOH group The compound contains a carboxylic acid group, which is a functional group consisting of a carbonyl group (C=O) and a hydroxyl group (-OH) bonded to the same carbon atom.
Trifluoromethyl substituent
Contains a CF3 group The compound has a trifluoromethyl group (CF3) as a substituent, which is a carbon atom bonded to three fluorine atoms.
Pharmaceutical and agricultural applications
Potential use in drug and agrochemical synthesis The compound has potential applications in the pharmaceutical and agricultural industries as a building block for the synthesis of various drugs and agrochemicals.
Biological activities
Antimicrobial and antifungal properties 1H-Imidazole-2-carboxylic acid, 5-(trifluoromethyl)has been studied for its potential biological activities, including its ability to inhibit the growth of microorganisms and fungi, making it a subject of interest for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 915230-46-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,5,2,3 and 0 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 915230-46:
(8*9)+(7*1)+(6*5)+(5*2)+(4*3)+(3*0)+(2*4)+(1*6)=145
145 % 10 = 5
So 915230-46-5 is a valid CAS Registry Number.
915230-46-5Relevant articles and documents
IMIDAZOLE CARBONYL COMPOUND
-
Page/Page column 57, (2010/09/17)
To develop an antibiotic having a novel mechanism of action, the present inventors have searched for a compound that has weak cytotoxicity, the physical property of high solubility in water, the effect of inhibiting both DNA gyrase GyrB and topoisomerase IV ParE subunits, and sufficient antibacterial activity. As a result, the present inventors have completed the present invention by finding that a compound of the present invention represented by the general formula (1), a pharmacologically acceptable salt thereof, and a prodrug thereof have desirable properties. The present invention provides a pharmaceutical composition (particularly, a preventive or therapeutic composition for infectious disease) comprising a compound represented by the formula (1), a pharmacologically acceptable salt thereof, or a prodrug thereof as an active ingredient.
